• Nenhum resultado encontrado

Asymptomatic neurosyphilis No specific

N/A
N/A
Protected

Academic year: 2019

Share "Asymptomatic neurosyphilis No specific"

Copied!
8
0
0

Texto

(1)

L

+'#!(" ./$#("!+ )3

' , 2 2

!' + '(

# #$ L +", '

' 00

3+$+ ' +$+$,+ ' ,24+ ' +$',, 4 +$ , 2/$'?>77 '=$' ', '+$$+ 3,' 024+ <% 0 +'$+2/$' ';;77 $++ + $0 ' 2/$, 4 ' $+$',2$$<%202+'$+ 0 $''' 2/$''+' ' +$4 ' + +' , '2

F8 ", +$2

$.E1%* .H

:B $%0%!A1 M%139:%,$%0%$A" ,93A16K:0B"E(A%3,/ B_ """L"L5%7B_"""L"LD

M(!%,B%!N!!

/$5 ' BL(LD

O*G %3,%%,%% 07/, ,, .

F"(LED

-*1 *-/** 1* /+1+!" +G. G-*0**00- 001**-*0, *1*,* **G* +,*,,1* ,30U#.!V 0 * *,G-*0* 3*+ *+,* * G/*+D7E ,B+0G- *,13*1-+0* 0 * /0- /0-*1 +*U%.$V

** 00G. G- * +G-*0* /0-*$WPW,- *3*+ G-*0*UO.(V3 * 1*#"W,- * 3*0 G-*0*-*13* +-G * * *00U)V .*#!W.-*13*+01* *00U'V

0G +G-*0* D*1/ +0 *1 0E++ 00G +3**,*/G , * , * 3 0 - G + +G-*0*D 0*.1 0- * - 0G*E +,*/ !OG ,*, *UPV

7*, * -- 0 0** 0 -1*,G-*0*.*- *, 01* ,G*0*. U#".##V7*, ** * 2 , - * - 1 * 0 G G- * +G-*0*.- * 00G*1** *1/ +0 G-*0*. * + - * 300 /0-, 0G G- * +G-*0*+*1,*3 G , * + +0 D;E -* *00* U#!.#%V

(2)

L

,# 2

4 %"&G &0 0 2 0 23 / G- * 7-**/*G,!G 3*+ G- *,* . -0 *,%, *-* 0 +*132-* **-3*3 . 0+G/**./*+ 0 . 9+ */ 0*9 ** *1G *00,*- **,/ *J+ 00G-* ++3*+ G -/*+J+ 00G ** *G , *D* 0E *9+ ++ *,*JJ * *3 ,*0 1 0*>*,0 G * -0G - G. 0+ -* 03 +11*/, G0 * 23 *,,G J * *3 /* ,-*+/** D** G 0**E**1G. 0,G3 0+01* 0J * */ 0 0 0 +. 03J*G.,0J G ,+ * 0, , * 0 - 0G G-* -J* 0*1+--J*G3 2 D;1 $ZLOE G / 0 0 +* 0G*. 1+0 * 3*0 00D:E + *,,* 0M *0 * M 0 0 0G. **.10+ . 0 *+.--+. 1*+. 0*/,+ *+7 0 * G D7E 3 */ *,#NO#! * *1 -3 0 + +0*2*3 1 */ * 0 -+ 1 -* DE 3 G-.0 + 0**+ * 01*, 0,- * 01*& G*/ J * *, -* 0,0+*D5E/ 0 + 0 -0 G*D##$:L3

3*P"W ,0G-+ 0 00E. 0/ -*0/0 D!)O1L0E.10+ D(1L0E. 7*, #N($ 1 */8 Y *. *&, *.* *2 - * */* /+-* *00* 8D!$*00*+*- GE,!# G,+G-*0* 0,0+ >0D#""1- GE,#" G, 0 ** *0 5 +0+, * . G * ,+1* 3 1 */ +

%(%"$ 110+* *D4E

,** 1*,G-*0*01* 0 3,7D41 *& & 0E. 7D4&%"E.7&LD4E 1%( 2" D4 5E 0G *& & 0 -**/ +0 +B+ *+/*01* 0 / 0+ */ 0 0+0G- G4 +

,#)OL3

.8,PP(L3

.4L8 *,"#' +7&#/* 00 DGE,$.(""4 -*L0D%()01E- *-300 -00G /,*** 0 G-40+ -+ + ,!#& G +,-* *00*3#!:L3

,5 D#""W0G-+ 0 E.-*0/0,'!1L 0. -*0G03510+ DP1L0E & */7- *3 * 1 ,,+ +0 G/ 0+ *3* - *,* *- 0+ -+ +. +3

0,003&+-,# %

4OO&G &03*, 03*-*0-G 00 3*- * 0 >-*.3 * + ;>-* 03* #!& *G, J* .3 2./3*10 D_%"21E.-* (&*G, /* *.* 0* *0*G -*, 0 ,+* , -G * * * 3* 0- >*. 0-*0 *-*3**-/5/1 3 * ** --* 03* O& G*G,/ *1*,* 3*1, 0 +- * 3 */ .3**G,J+ 0-* +*G. *00* *+1+., */*10*/ */ G* 0 J * * / 0 3 2 0+* - *. G DZL$ZE. ,*0 D%P!o

(3)

L )*: ,19=(/%

23+G-*0*N* 1* 0 G ** 5,* 0 /* DEU%#V 0 *G, 01G 701GD7EU%!V

%3 ,+G-*0* G:0 01 *> *D:EU$"V. ,* 0 /*DEU%#V. 0 *G, 01G 701G D7EU%!V

8 ,, 8C

D & **/5&4

, 0 G*D5: + 5&18*J_")" _#"L3

E 5-* 5: +_#"L3

0/ D_"O"1L0E

,, */5&7 */5&7 0)5B:%,, G/9B6(( !%,% P0B ,,, =$&B=%, %$% &%%*

8 65 ,, 8C

8#!&!$L G*/ 8#'&!$L G*/ 8"#O+L21L G D!&$L$E. D%&$L$E.#"&#$ */#O G

#$ G40 */N G40 */N 8#!L G* 8!$L G* Z- *$J Z- *$JO""1 O""1#"&#$ G #"&#$ G

- *,* G- * G- *

* +G-*0* +G-*0*

-$ ,5J * ** ,5J * **

-,N8%J -,N8% !$*5 J!$*.-0+ J * * G* 5J * * , 7&*, - * #G

(4)

L"

G 3*0 * .0+2 G*3* +-*0* /G- * D N#!%BL 0E 0**3,+* 1+0 *. 10+ . 0 0*/,+ *.+* 0G* * *1 -+73 */ * , #N#!' * 0 3 0 5 J * */ 0+ 0 -0 G*DO" :L3

3*O#W,0G-+ 0 00 $PW-0G-+ 0 00E. 0/ -* 0/0D#$#1L0E.10+ D%$1L0E. 7* ,#N' 1 */8 Y *. *&, *.* *2 0 J 110+* *,'6%(("0 6"(.(2 6 ("(""$" +G-*0* 3*-* *00*8D!$*00* *0GE3 1+ *+,!# G **. 0 2 >0D!""13* *0GE3 ** , 0 ** *3 *-/, . *1 0*1 , 0 ,+*.+ - * *G- */0 5 +0+31 */, * .G * ,+1* + 4 ,* G-*0* * 1* 7&#01* D4 :& 0E ,*7&# *, *01* 0 ,7D41 *& & 0E.7D4& %"E.7&LD4E 1%(2"D4 5E31 */** 0*+/*01* 0 / 0+ */ 0 0+0G- G4 + ,%$%L3

.8,P'#L 3

.4L8 *,"%O

+7&#/* 00 DGE,#.!""4 -*L0D%"'01E4*/* 0 -G3 1+ 3* >*/+*. 0 */+* /* -* +01* 0 0** 0 +*-/ 3 5J * * ,!#& G +,-* *00* 3#!:L3

D#""W0G-+ 0 E. *00/ -*0/0D(#1L0E. 010+ D%)1L0E 7 * , #N! 1 *5* *01* 031 */ - *3 * 1 ,,003& +- , +7 3 */3* *,#N#( 5 73 0 G& */4**. *+01* 0 + *-/ 3* 0G- G4 +,(O)L

3

.8,#!('L

3

4L8 *,"O!

G-*0***00 9 +,**G* /0-*1 +* * , 4* +-.- * +0 0G +-U#$V #PPP./ 00* * ,-* G GG-*0**3 !O-#"".""" --+0 *.+ **3* * *1 #"$!-#""."""--+0 *U#OV80 00G. P"".""" ,-1 3 *, 3*G-*0*/GG .+0*1*%(".""" , 0-* 0 **,!)".""" *, 3**+- *- *U#(V

J * * ,+G-*0**+23. **+ 0 3G0G- *3*G-*0* /0-+*0** ,B+ 1 3* 5*J *.*2, --+0 * J *. B+ G , -* 3* *** . ** +,* +G-*0*U#)V

4G- * +G-*0** +*1 + -* G GG-*0*U#'.#PV +*10 G-*0**7- *U!"V

(5)

LF

*+ . - * *-01* M D%E + G-*0** *1**. *0 G-. *, * 0 /- 0*+ *0 *,0 *

G-*0* 7*, * , 00G0 U$V4 0* +/*3* 0+*1%"+*7 -/ 0 1- *3*-* G* 1*, G-*0* 3 *, *-/ 0 , #O)W*U!%V /*3.0 2. 0 *10*1-/*7*1,/G- * * 13*G-*0*/ 0+* / G-*0* *+ *-*2, ,7 *, * *2 +0, 23 *+ + + *+1* 0+0 *U!$. !OV* * ,G-*0* 17&*, **/*+ 0**,,* +0* .+-/ 0 +* /3/* ,-/*+J-+6%"$

*%W%OW7&-**/- *U!".!(.!)V4 +G + G . 0U!'V*0*>. >*0D#PP'E.+*1- 0D454&4E 3 G-*0*-/ 0 ,%)!W 1(O" 7&#&*, - *

+7*, * G 0 + 0 *G,G-*0*G* *1--*G, * -1+G-*0*. *1 0 G -* , , +G-*0*. * *1 /*G , *, * , +G-*0*.*1 -G,-* G G G-*0* * B+ U#!V +01* 0 *, *,G-*0*,B+0G * 17&*, - * + *1** *1/ +0 * U(V +0 G-*0*.-*,* -*++G. *10G * 3*+G-*0* B+* -+* -- .*-,* 0 - ,-* G*, *U!PV4-- 0G. 0/+G**/0/* 00 0GG-*0* U(V * * , G- * +G-*0**- 0G+* +* 35 0***%"W$"W,- * 3*-* G GG-*0*U#'.!#V 0G G- * +G-*0*. * 0+*1 *1/ +0 - * 3 * + ,* - . 3 03 G * - *./*-&-* *00*

*,,* 0* 1*,G-*0** *1**. - * 00G*7&*, - *.+0* 0+ +, +0G-+ 0 *1** + + +0*. G- * G* G D1*-0 *.- **G * ***G *E. -> *, * D- * 00GJ-0 * G- * ** * E.--+** /* 0*, *D1 G1 0/*+.-/*+E 7*0, * 0 *1**** 0G 1 ,*1- * 00G 0G--0*, */ * D1 0G- E 0 *+*- * * * *,,* 0 * 1* , 0G-+ 0 *1**

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

(6)

L

G- * +G-*0*U#P.%%.%$.%(V5 0& -**/57+0 + * 00G U%%V. 0+1 0G+0 * * 5&54&4***/ 5& 7,* 1*,+G-*0*.+** 0-, 0&-**/+0 +, 0 * * *,,+* , + *+10+0**54 ;4& / 0 + - 0 ***5G *10G - *,* + G*0, 0-**/+0+0 * *U#)V+,

*01* ,**1 * +G-*0* - *,* * 0++0*, 0*, * +0*-03* 0+ ** * *1 0 - G 0 / * * 7&*, - * 3* +G-*0* 0*20G ,0 * * * ,G-*0** *1****1+-U#%V / 00.+, 1* * 1*1D;E * +,/*+ 0*> * ,3* 3/. +,+0 * * 1* , -* 0 -0* * , / +0 * + * 0 1U%PV *01* 0,**1+0*1 , 0+*// +0 * + *, * **. *1 * 00*3*3*+ , 9 *1.*,,+ J & J* 0, 0 . 3* * . 0+1- *,* . *- * *,,* 0* 1*,+G-*0*U%PV

,+G-*0* G :0 01 *> *D:E., * 0 /* DE 0 *G, 01G 701G D7E 0** 0! -G, * * */-* *00*8#!!$- G,#"#$ G U%#.$"V40+1- *-* *00*D!$ *0GE * 3* 0- *D$JO""1E +0 * 0 */1*., * + +0 -* *00* 1* *0G -+ -* * 0-* *00* **5 U$#V4 + *G - *G ---* 2**1 **> **** 3*/G

- * 001* -* *00*- * 0 B+**1 +, 0 */ -G. 0JG G 0*!"" 1/G#!+,$32*/JG G 0* ** U$"V,* JD#1!1; *0G. ,#"#$ GE +U$!V.+ , *0+ /-.- * 00G*7& *, - *U$%V

,,, */, , +G-*0* 0** 0-* +D3* 1 00G *-/*- G ++G-*0* G*-1000G-* E 0 G,**15: + +0 / ( 5+0 *0G 0G!G ,. +0 * + , *0+,G- * +G-*0* , 3* 7 -* *00* / - * 7 *, - *U#".#%.#PV5+.** +*05: +* 0.5 J * *+0-,/G(. 3* 0*, 1*5 : +.3*0-* 0** , 0*- U%#V40+1 0*> *,5 -0 G*3**( , 3 -* 9*G,+G-*0*- * U#"V.** 5 0** 3**%( , UOV .5&7 */*G -*-* B+ U#".#P.%%V

5* 00G.3 / *3 ,*10G */ */* 0 -G D44E J 0G0*,- ,- **, 3* 7* #PPOL#PP(5++* B+* 0 *,G*- ,*44 + 0*G. 1 ,+G-*0**7& *, --+0 *

- , 3 3 *- ,G-*0***,,* 0* 1*, - *3* +*1 0G * ** 0 **-3*7*, **- ,7*, * 0** 0 +. - 5*- *,G-*0* * 0 001 0** * **3 +G

(7)

LE

#

G .%&A8VAP%9A%,M:! *: , $%5%BA% :,&%%))* "B("

)!% %0A/%,A/6A%,)*: , :!M%M:&%%)): "BD " 1 1 )*: ,A *: ,A :,,A %

)%))% E"B(E

F $!:%,1A) : 1A&%,/A%, %,,%%.%%8:.%, 9=)7G%!%))* FBF"E(F P, M0 G%! *: , 0,

S: %!%,%):* BF"(F

E 1 1A9%!,,$A% $MM !% !!* . *: ,% :%!1

%))> "BLD(L

D $10AM!,*$A%%6/) *: , % *: , % :* % %!)1%))< LBE(L

L .%M8$=AP,M0AG%!%A%,M %,* % ,% *: , %, . *!B :%,, %%,%, 61%):* E"BDD(L

.%==%/0)*: ,!%%!%%! )7G%!%)): EBE(D

6)1AM%1MA6$A%,G : *!:!%*: , (%. :,,6:% 9=SM, 1%))- ""BFE(D"

)3% 10A S $ M !% !!*. !%% *: ,S,*%))* FBL"(F

$AG*1A5,,% %%, **: ,* !%!!*.SM,1

%):* "EBE(D

" V%3A$A%$0S*: , !:%%.* !% !!*. S,%))? BF"( F 6$A0 (9)$AG%MA%,%

%, *: , ! :,%%, 7%!%B !:% :% ,*A)%%/0$

6( ( S 9!% /% ,

%))C DB"EE(D

00 0 % 0, % /. /!%*%%**: ,IT)%A 11P$11P8,*$:<>>% B"(D E 000%0,%/.6,%,

% ,!% % %% % :, %, % 11P$ 1 1 P8,* $:

%))) FL)::,B(E

D 0%%3A/% $S*: ,B6*$A 6$0%8`0,%,S,*0($H1 / ,%,: %B&::P,,%!;P,8A<>>> L &8 %)A98MPA98)A%,.%

%, . *! *6( (B !:,%%% %:*1

%):: BL(E

1%% 01A 0 , 0PA 98 MP"

A %, 0:%,,:!%,%% %,**: , S,%)); BEL(D

9,!/A&%$A&%,1MA%,/.%, *: , !%!!*.( :% ,%*: ,!1%))< "B( )!A$/S*: , S,%):; FBEE(" 1 99A 1 1 *: , !

1%)?; FB(L"

" ,81MA&.P0A)&1M9=:.%, :% *: ,AT)%)7G%!

<>>> DB"(

F 6,%$1A&8 %)A/,!!5A%,6%, ,%%%8% !%!!* .)%):: BFD(

>G0A0%$HA6,%A%,G %% *: , 8 !%!!*. :% % 7%,,* %! %, 1%))> BD(" E %P$A,&1A1! :.%,*: ,% ( 9=)G)%))? FB(

D A 1%3(=%343 0A,.%3 1A %, S*: , 9=( :% M 0, 1,%)); FBLEF(LE

L 0%!$A%0A&!%A%,/.%, (*9=(% 7%,:%%, %!,:% %3,%%

B0$B %%,P,)

0 6.% 6.%B 0HS6$M\ )3,%A%)):

/!!%%%. ,% *: ,A : % *: , !:,, %:*A% , !% !!* . % : H: %,!,*<>>> B("

" 9%MAM,)AG$S*: , :% )S!%0,S !

%))* DB(

" 000%0,%/.L 6,%!7%,,*%!% 11P$11P8,*$:%)): FDB(E

" S)=A S ,% ) !%,* % =,*AH%6*%,*A%1%, 1,*B )7%,,* G%! % %%G %:*6,A%))*

(8)

LD

"" 9% 6 )*: , % % %: !%81%):C FB"EL(DE "F P, M0A 9 M9A G%!% 0%,

.*!.,.!%,*%,%*: ,B :,!%*!:!%*: ,S, )%):: LLB("

" G!,16A9,!/AH&A&%$ M.%,%*: ,9=(.%, 0,%))- LBLL(F

"E 1%&%)A&5*: , .%,%% ,%%*()7G%! %))C "B"(F

"D 9AT4 %SA1% %$6%,.%,% ,,%, % % 0)5 6 7 %*: ,)7G%%))> DBD "L &5A ) ! &A V%, 1 )% ,%%*%*: , )G)<>>> BF("F

" ,, G0A !% 9A / 1A %, S*: , 9=(:. % 9=(%. :%B !% ! S%,

%)); EBD"(

F P9H%TS)B1%%!7%,,*%! %P9H6/GM1F$.A6.%A%))* F 98MPA1%%014*: ,%,S

M,1%))< "EBE(

F 1%%01A/A1 0%,:,* .%,%%7%:,,6%%! % * : , ! % !!*.(.%,0, <>>> "BF(F

F" ,,1MA$/6A1 1%,$: ,%*: ,*: ,%7 %:* : !%!!*. !1%))< "BFL(L

Referências

Documentos relacionados

(27) Deste modo, quando há suspeita de infecção primária por CMV na gravidez deve ser feito o diagnóstico por serologia para determinar o risco de transmissão para

Filipa Sousa, Pedro Neto, Ana Araújo, Fani Ribeiro, Inês Zão, Marcelo Aveiro, Mariana Silva Leal, Gorete Jesus, Rosa Jorge. XXIV Reunião Nacional

Objective: The purpose of the present study was to prospectively quantify the normal limits of brain perfusion using specific software in a group of asymptomatic young

de integ-ração~marginal:í2:a.ção desses gl.&#34;u.pos -, e extrapolados uni- -versabnente em negativo pal'a as situações sociais c:liversas do p()nto de partida, esses

E-ISSN:2175-8255 128 Desta forma, a partir de um levantamento bibliográfico, é feita uma análise desses fluidos em relação à presença dos aditivos e como eles podem

The distinction between present and fu- ture illness allows for the recognition of specific preventive actions in asymptomatic people (in which the illness that affects a

Oculomotor nerve palsy as the presenting symptom of gummatous neurosyphilis and human immunodeficiency virus infection: clinical response to treatment. Axial T1-weighted brain

O documento exigido no item 5.1, e, do Edital, é uma certidão Negativa de Débitos relativos aos Tributos Federais e à Dívida Ativa da União (CND) ou Certidão Positiva com Efeitos de